A large study of older African-Americans has found taking common medications with anticholinergic effects was correlated with an increased risk of developing mild cognitive impairment.
Anticholinergics are widely used for a variety of common medical conditions including insomnia, allergies, or incontinence, and many are sold over the counter. Now a large six-year study of older African-Americans has found that taking one anticholinergic significantly increased an individual's risk of developing mild cognitive impairment and taking two of these drugs doubled this risk. The risk was greater for those who didn’t have the ‘Alzheimer’s gene’, APOE-e4.
Alzheimer's mice significantly benefited from taking a drug used to treat hypertension.
Two mouse experiments have found that the drug carvedilol, prescribed for the treatment of hypertension, significantly improved synaptic transmission in Alzheimer's disease-type brains, and at a behavioral level significantly improved learning and memory.
Arrieta-Cruz, I. et al. 2010. Carvedilol Reestablishes Long-Term Potentiation in a Mouse Model of Alzheimer’s Disease. Journal of Alzheimer's Disease, 21 (2), in press.
A rat study shows how Ritalin improves concentration and, it now appears, speed of learning. The finding may help the development of better-targeted drugs.
A rat study shows how Ritalin improves concentration and, it now appears, speed of learning. The study reveals that it does this by increasing the activity of dopamine at two specific types of neurotransmitterreceptors in the amygdala. The dopamine receptor tagged “D2” appears to control the ability to stay focused on a task, while the D1 receptor underlies learning efficiency. The finding may help the development of better-targeted drugs.
